Related Experiment Videos
Percutaneous transluminal coronary angioplasty: the early Dunedin experience
Insights
Percutaneous transluminal coronary angioplasty (PTCA) is effective for treating coronary artery disease, achieving high success rates, particularly in single-vessel disease. PTCA offers a viable alternative to bypass surgery for many patients.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide.
- Percutaneous transluminal coronary angioplasty (PTCA) has emerged as a key revascularization strategy.
- Evaluating the outcomes of PTCA in a real-world clinical setting is crucial for understanding its efficacy.
Purpose of the Study:
- To assess the efficacy and outcomes of percutaneous transluminal coronary angioplasty (PTCA) for treating coronary artery disease.
- To compare PTCA success rates in patients with single-vessel versus multiple-vessel disease.
- To evaluate the effectiveness of PTCA in relieving symptoms and its role as an alternative to coronary artery bypass surgery.
Main Methods:
- Retrospective analysis of 50 patients undergoing PTCA at Dunedin Hospital between May 1981 and an unspecified end date.
- Data collection included patient demographics, angina classification, lesion location, procedural success, and clinical outcomes.
- Primary success defined as angiographic stenosis reduction without myocardial infarction or emergency bypass.
Main Results:
- Overall primary success rate was 77% for single-vessel disease and 62% for multiple-vessel disease.
- Procedural success varied by coronary artery: 81% for anterior descending, 67% for circumflex, and 58% for right coronary artery.
- Sixty-eight percent of patients were rendered asymptomatic post-successful PTCA; 10% required emergency coronary bypass, with one mortality.
Conclusions:
- Percutaneous transluminal coronary angioplasty is a valuable treatment option for symptomatic coronary artery disease.
- PTCA demonstrates favorable outcomes, especially in patients with single-vessel disease.
- PTCA serves as a practical alternative to coronary artery bypass surgery for selected patients with both single and multiple vessel coronary disease.
Abstract:
Since May 1981 39 men and 11 women (mean age 55 years) have undergone percutaneous transluminal coronary angioplasty at Dunedin Hospital. Angioplasty was performed in 34 (68%) patients with stable angina, 13 (26%) with unstable angina and in three (6%) patients with acute myocardial infarction. Primary success (reduction in angiographic stenosis without associated myocardial infarction or emergency coronary bypass) was achieved in 77% of those patients with single vessel coronary disease (27 of 35 procedures) and of 62% in those patients with multiple vessel disease (16 of 26 procedures). Successful angioplasty was obtained in 81% (25/31) of those patients with anterior descending disease, 67% (4/6) of those with circumflex disease and 58% 14/24) of patients with right coronary disease. Thirty-four patients (68%) following successful angioplasty were rendered asymptomatic. Five (10%) underwent emergency coronary bypass grafting and one of these patients died. Percutaneous transluminal coronary angioplasty is a useful alternative to coronary artery bypass surgery and may be performed in a majority of patients with symptomatic single vessel coronary artery disease and in selected individuals with multiple vessel coronary disease.